L About
Lunit develops AI for cancer screening and treatment, including its FDA-cleared Lunit INSIGHT imaging suite (used at 10,000+ sites across 65+ countries) and the Lunit SCOPE biomarker platform. Founded 2013 by KAIST graduates; CEO Brandon Suh. Public on Korea's KOSDAQ since July 2022.
Stock Price
328130.KQData provided by TradingView & Yahoo Finance
Focus Areas
Technology Focus
healthcare ai medical imaging diagnostics
Key People 1
- Brandon Suh
Quick Stats
- Founded
- 2013
- Status
- public
- Type
- commercial
Explore More
Similar Companies
Ranked by shared focus areas, technology, and location.
D
Dr CADx
Bulawayo, Zimbabwe
85%
2 shared categories
3 shared AI types
Healthcare AIMedical Imaging
CheckEye
Kyiv, Ukraine
85%
2 shared categories
3 shared AI types
Healthcare AIMedical Imaging
Huna
Sao Paulo, Brazil
70%
2 shared categories
2 shared AI types
Healthcare AIMedical Imaging
Insightiv
Kigali, Rwanda
70%
2 shared categories
2 shared AI types
Healthcare AIMedical Imaging